Seroprevalence of HBV and HCV in chronic liver disease patients: The case of three public hospital in Addis Ababa, Ethiopia,Used

Seroprevalence of HBV and HCV in chronic liver disease patients: The case of three public hospital in Addis Ababa, Ethiopia,Used

In Stock
SKU: DADAX3846519855
Brand: LAP Lambert Academic Publishing
Sale price$83.54 Regular price$119.34
Save $35.80
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

Hepatitis B and C viruses (HBV & HCV) are hepatotropic viruses causing viral hepatitis, chronic liver disease and hepatocellular carcinoma. Hepatitis B and C virus infections are still major public health problems around the globe. Both of these viruses are transmitted mainly through the parenteral route and therefore a dual infection of these viruses can occur and even persists in the same patient. They are prevalent in different parts of the world including Ethiopia. In view of this, hospital based crosssectional study was conducted in three public hospitals of Addis Ababa over a period of 7 months (Nov 2010 May 2011) on clinically diagnosed chronic liver disease patients. Serum samples from each volunteering patients was screened for the presence of HBsAg and antiHCV Ab.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed